Glycosaminoglycan binding facilitates entry of a bacterial pathogen into central nervous systems

Yung-Chi Chang1, Zhipeng Wang, Lindsay A Flax

  • 1Glycobiology Research and Training Center, University of California, San Diego, La Jolla, California, United States of America.

Plos Pathogens
|July 7, 2011
PubMed

Insights

Group B Streptococcus uses glycosaminoglycan (GAG) interactions to invade the central nervous system. Targeting these bacterial-GAG interactions may offer new therapies for meningitis and other CNS infections.

Area of Science:

  • Microbiology
  • Neuroscience
  • Infectious Diseases

Background:

  • Certain microbes breach the blood-brain barrier (BBB) by invading brain microvascular endothelial cells (BMECs).
  • Group B Streptococcus (GBS) is a leading cause of meningitis and central nervous system (CNS) infection.

Purpose of the Study:

  • To investigate the role of glycosaminoglycan (GAG) interactions in GBS entry into the CNS.
  • To explore GAG-binding domains of GBS surface proteins as potential therapeutic targets.

Main Methods:

  • Utilized insect (Drosophila) and mammalian infection models.
  • Employed site-directed mutagenesis of the GAG-binding domain of GBS alpha C protein.
  • Assessed GBS adherence and invasion of human BMECs in vitro.
  • Genetically impaired GAG expression in model organisms.

Main Results:

  • Mutagenesis of the GAG-binding domain impeded GBS penetration of the Drosophila BBB and reduced adherence/invasion of human BMECs.
  • Impaired GAG expression in flies and mice decreased GBS dissemination into the brain.
  • Bacterial-GAG interactions were identified as crucial for CNS infection pathogenesis.

Conclusions:

  • Bacterial-GAG interactions play a significant role in the pathogenesis of CNS infections like meningitis.
  • Drosophila serves as a valuable model for screening therapeutic molecules targeting pathogen-GAG interactions.
  • Interruption of GAG-binding domains presents a potential strategy for preventing CNS entry of pathogens.

Related Concept Videos

Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Determinants of Bacterial Pathogenicity and Virulence01:20

Determinants of Bacterial Pathogenicity and Virulence

Pathogenic bacteria employ a variety of strategies to establish infections, including the secretion of extracellular enzymes that act as potent virulence factors. These enzymes facilitate bacterial colonization of host tissues and help evade immune surveillance. By targeting structural components of host tissues and interfering with immune mechanisms, these enzymes play a pivotal role in disease progression.Extracellular Enzymes Facilitating Tissue Invasion: Several bacterial pathogens secrete...
Colonisation of Pathogens01:25

Colonisation of Pathogens

Pathogen colonization of host tissues is a critical step in the development of infectious diseases. Various pathogenic microorganisms, including bacteria, fungi, viruses, and protozoa, have evolved complex strategies to attach to, invade, and persist within host environments. These mechanisms enable pathogens to establish infections, evade immune responses, and resist antimicrobial treatments.Attachment to Host CellsIn bacteria, colonization typically begins with adherence to host epithelial...
Glycosaminoglycans01:23

Glycosaminoglycans

Glycosaminoglycans (GAGs), also known as mucopolysaccharides, are long and linear polymers comprising of specific repeating disaccharides - the amino sugar that can be N-acetylglucosamine or N-acetylgalactosamine, and a uronic acid that is usually glucuronic acid or iduronic acid.
GAGS are found in the extracellular matrix of vertebrates, invertebrates, and bacteria. Due to their polar nature they attract water, and serve as excellent lubricants or shock absorbers in an animal body.
Hyaluronic...
Proteoglycans01:05

Proteoglycans

Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...